A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is
Purpose: To evaluate preoperative asymptomatic bacteriuria (ASB) treatment on the reduction of early-periprosthetic joint infections (early-PJIs) after hip hemiarthroplasty (HHA) for fracture.Methods: Open-label, multicentre RCT comparing 3gr of fosfomycin-trometamol with non-treatment. A parallel follow-up cohort without ASB was established. Primary outcome: early-PJI within 3 months after HHA. Results: 594 patients enrolled (mean age 84.3years); 152(25%) with ASB (77 treated with fosfomycindoi:10.21203/rs.3.rs-203528/v1 fatcat:gwciexnnqzgjxeokxpx5l6xsyy